StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a buy rating on the health services provider’s stock. A number of other research firms have also recently commented on AMED. Jefferies Financial Group cut Amedisys from a buy rating to […]
Riverbridge Partners LLC increased its position in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 2.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,559,572 shares of the health services provider’s stock after acquiring an additional 34,261 shares during the period. Amedisys comprises about […]
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have earned an average recommendation of “Hold” from the thirteen analysts that are currently covering the company, Marketbeat reports. Ten analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among […]
SG Americas Securities LLC grew its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 2,744.5% in the second quarter, Holdings Channel.com reports. The fund owned 113,553 shares of the health services provider’s stock after buying an additional 109,561 shares during the quarter. SG Americas Securities LLC’s holdings in Amedisys were worth $10,383,000 […]
Equities researchers at StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Get Free Report) in a report released on Wednesday. The firm set a “buy” rating on the health services provider’s stock. AMED has been the subject of a number of other research reports. Barclays boosted their price target on Amedisys from $88.00 to […]